293480.KS
Price:
$11620
Market Cap:
$201.02B
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-10-02
Stock Exchange
KSC
Ticker
293480.KS
According to Hana Pharm Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 7.44%. This represents a change of 302.09% compared to the average of 1.85% of the last 4 quarters.
The mean historical ROE of Hana Pharm Co., Ltd. over the last ten years is 14.37%. The current 7.44% ROE has changed -48.27% with respect to the historical average. Over the past ten years (40 quarters), 293480.KS's ROE was at its highest in in the June 2018 quarter at 6.59%. The ROE was at its lowest in in the December 2020 quarter at -1.80%.
Average
14.37%
Median
11.93%
Minimum
6.41%
Maximum
31.42%
Discovering the peaks and valleys of Hana Pharm Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 106.42%
Maximum Annual ROE = 31.42%
Minimum Annual Increase = -57.57%
Minimum Annual ROE = 6.41%
Year | ROE | Change |
---|---|---|
2024 | 6.87% | -14.45% |
2023 | 8.03% | -11.29% |
2022 | 9.06% | -18.56% |
2021 | 11.12% | 73.53% |
2020 | 6.41% | -50.11% |
2019 | 12.85% | 0.82% |
2018 | 12.74% | -57.57% |
2017 | 30.03% | -4.42% |
2016 | 31.42% | 106.42% |
The current ROE of Hana Pharm Co., Ltd. (293480.KS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.99%
5-year avg
8.30%
10-year avg
14.37%
Hana Pharm Co., Ltd.’s ROE is greater than Jeil Pharmaceutical Co.,Ltd (-17.51%), greater than Woongjin Thinkbig Co., Ltd. (-6.38%), less than JW Lifescience Corporation (25.47%), less than Hanmi Pharm. Co., Ltd. (11.47%), greater than Dong Sung Bio Pharm.Co.,Ltd. (-17.11%),
Company | ROE | Market cap |
---|---|---|
-17.51% | $182.58B | |
-6.38% | $179.17B | |
25.47% | $175.75B | |
11.47% | $3.04T | |
-17.11% | $80.03B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hana Pharm Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hana Pharm Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Hana Pharm Co., Ltd.'s ROE?
How is the ROE calculated for Hana Pharm Co., Ltd. (293480.KS)?
What is the highest ROE for Hana Pharm Co., Ltd. (293480.KS)?
What is the 3-year average ROE for Hana Pharm Co., Ltd. (293480.KS)?
What is the 5-year average ROE for Hana Pharm Co., Ltd. (293480.KS)?
How does the current ROE for Hana Pharm Co., Ltd. (293480.KS) compare to its historical average?